Literature DB >> 11889599

Relationship of p21 (waf1/cip1) and differentiation in chondrosarcoma cells.

Koji Hiraoka1, Michihisa Zenmyo, Setsuro Komiya, Rikimaru Kawabata, Masahiro Yokouchi, Ritsu Suzuki, Tetsuya Hamada, Seiya Kato, Kensei Nagata.   

Abstract

The histological grade of chondrosarcoma correlates well with their clinical behavior and with the patient's survival duration. We have previously demonstrated that p21 was expressed in the hypertrophic chondrocytes of the growth plate. To assess the relationship of p21 (waf1/cip1) to cell differentiation in chondrosarcoma, we examined the p21 expression in 14 cases of chondrosarcoma immunohistochemically and the induction of p21 by insulin-like growth factor-I (IGF-I) during cell differentiation in SW1353 chondrosarcoma cells. p21 immunoreactivity was seen in well-differentiated chondrosarcoma cells and was mutually exclusive with MIB1 reactivity in grade-1 chondrosarcoma. In vitro, the proteoglycan synthesis of SW1353 cells was increased by IGF-I in a dose-dependent manner. However, cell proliferation was not markedly stimulated. Overexpressions of p21 mRNA and p21 protein in SW1353 cells were induced by IGF-I 100 ng/ml. Our results suggested that the p21 expression was directly related to tumor differentiation and that the p21 expression was an important mediator for IGF-I in chondrosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11889599     DOI: 10.1007/s004280100495

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  5 in total

1.  Chondrosarcoma cell differentiation.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

2.  Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.

Authors:  Michihisa Zenmyo; Akihide Tanimoto; Harutoshi Sakakima; Masahiro Yokouchi; Satoshi Nagano; Takuya Yamamoto; Yasuhiro Ishido; Setsuro Komiya; Kosei Ijiri
Journal:  Diagn Pathol       Date:  2010-10-13       Impact factor: 2.644

3.  Lumican mediates HTB94 chondrosarcoma cell growth via an IGF‑IR/Erk1/2 axis.

Authors:  Antonis Papoutsidakis; Eirini Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Demetrios A Spandidos; Aristidis Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Int J Oncol       Date:  2020-07-06       Impact factor: 5.650

Review 4.  The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.

Authors:  Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

Review 5.  The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.

Authors:  George N Tzanakakis; Eirini-Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Kyoko Hida; Monica Neagu; Aristidis M Tsatsakis; Dragana Nikitovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.